Clinical Trials Browser

Phase 2 × Pancreatic Ductal Adenocarcinoma × S 1 (combination) × Clear all

NCT03316326 2017-10-20

S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer

Phase 2 Unknown

Gastrointestinal

Pancreatic Ductal Adenocarcinoma